Zobrazeno 1 - 10
of 75
pro vyhledávání: '"Jeannine M. Coburn"'
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 3, p 1462 (2024)
Bacterial-derived cellulose (BC) has been studied as a promising material for biomedical applications, including wound care, due to its biocompatibility, water-holding capacity, liquid/gas permeability, and handleability properties. Although BC has b
Externí odkaz:
https://doaj.org/article/916bc42ba1b54763ab1ff3b63b2aeccf
Autor:
Kristy L. Townsend, Eleanor Pritchard, Jeannine M. Coburn, Young Mi Kwon, Magdalena Blaszkiewicz, Matthew D. Lynes, David L. Kaplan, Yu-Hua Tseng
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 10 (2022)
Objective: Increasing the mass and/or activity of brown adipose tissue (BAT) is one promising avenue for treating obesity and related metabolic conditions, given that BAT has a high potential for energy expenditure and is capable of improving glucose
Externí odkaz:
https://doaj.org/article/53b270743bda4d0b91f143c84a529e10
Autor:
Kimberly J. Ornell, Jordan S. Taylor, Jasmine Zeki, Naohiko Ikegaki, Hiroyuki Shimada, Jeannine M. Coburn, Bill Chiu
Publikováno v:
Cancer Medicine, Vol 9, Iss 8, Pp 2891-2903 (2020)
Abstract Immunotherapy targeting GD2 is a primary treatment for patients with high‐risk neuroblastoma. Dinutuximab is a monoclonal antibody with great clinical promise but is limited by side effects such as severe pain. Local delivery has emerged a
Externí odkaz:
https://doaj.org/article/01e8782bbfaf4100ba124fadbc3a0521
Autor:
Kimberly J. Ornell, Jeannine M. Coburn
Publikováno v:
BMC Biomedical Engineering, Vol 1, Iss 1, Pp 1-18 (2019)
Abstract Despite advances in cancer therapeutics, particularly in the area of immuno-oncology, successful treatment of neuroblastoma (NB) remains a challenge. NB is the most common cancer in infants under 1 year of age, and accounts for approximately
Externí odkaz:
https://doaj.org/article/6bdd1649286c41ae9335c441f09a8462
Autor:
Kyle H. Bond, Takuto Chiba, Kieran P. H. Wynne, Calvin P. H. Vary, Sunder Sims-Lucas, Jeannine M. Coburn, Leif Oxburgh
Publikováno v:
Cancers, Vol 13, Iss 23, p 5873 (2021)
Clear cell renal cell carcinoma (ccRCC) is the most common kidney cancer and is often caused by mutations in the oxygen-sensing machinery of kidney epithelial cells. Due to its pseudo-hypoxic state, ccRCC recruits extensive vasculature and other stro
Externí odkaz:
https://doaj.org/article/f883b424567f4892bb03b365212001f8
Autor:
Mercedes G. Montalbán, Jeannine M. Coburn, A. Abel Lozano-Pérez, José L. Cenis, Gloria Víllora, David L. Kaplan
Publikováno v:
Nanomaterials, Vol 8, Iss 2, p 126 (2018)
Curcumin, extracted from the rhizome of Curcuma longa, has been widely used in medicine for centuries due to its anti-inflammatory, anti-cancer, anti-oxidant and anti-microbial effects. However, its bioavailability during treatments is poor because o
Externí odkaz:
https://doaj.org/article/9c985164bbb249f59f05a38b1cfb9c46
Autor:
Olga Lakiza, Namrata Setia, Alyx Vogle, Ralph R. Weichselbaum, Katelyn S Mistretta, Xavier M. Keutgen, Paul R. Miller, Kimberly J. Ornell, Jeannine M. Coburn, Jelani Williams
Publikováno v:
Annals of Surgical Oncology. 28:8532-8543
Pancreatic neuroendocrine tumors (PanNETs) are increasingly common. Experts debate whether small tumors should be resected. Tumor destruction via injection of cytotoxic agents could offer a minimal invasive approach to this controversy. We hypothesiz
Autor:
Elizabeth M. van Zyl, Mitchell A. Kennedy, Wendy Nason, Sawyer J. Fenlon, Eric M. Young, Luis J. Smith, Surita R. Bhatia, Jeannine M. Coburn
Publikováno v:
Biomaterials Advances. 148:213345
Publikováno v:
Journal of biomedical materials research. Part AREFERENCES. 111(1)
Lyophilization of protein solutions, such as silk fibroin (silk), produces porous scaffolds useful for tissue engineering (TE). The impact of modifying lyophilization primary drying parameters on scaffold properties has not yet been explored previous
Publikováno v:
J Biomed Mater Res A
Neuroblastoma is the most common extracranial solid tumor of childhood and is associated with poor survival in high risk patients. Recently, dinutuximab (DNX) has emerged as an effective immunotherapy to treat patients with high risk neuroblastoma. D